VIMENTIN
HOMO SAPIENS
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 101–137 | Fragment:1A, RESIDUES 102-138 | SO4 SULFATE ION × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:pH 6.5;2.0M AMMONIUM ACETATE, 10%(V/V) DIOXANE, 0.1M MES/NA, PH6.5, pH 6.50 | Resolution 1.40 Å R-free 0.216 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1GK7 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1GK4 HUMAN VIMENTIN COIL 2B FRAGMENT (CYS2) Deposited 2001-08-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
Chain B
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
|
Not recorded | ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;0.17M NA ACETATE, 25.5% PEG8000, 0.1M CACODYLATE, PH6.5, pH 6.50
|
Resolution 2.30 Å R-free 0.262 |
| 1GK4 HUMAN VIMENTIN COIL 2B FRAGMENT (CYS2) Deposited 2001-08-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
Chain D
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;0.17M NA ACETATE, 25.5% PEG8000, 0.1M CACODYLATE, PH6.5, pH 6.50
|
Resolution 2.30 Å R-free 0.262 |
| 1GK4 HUMAN VIMENTIN COIL 2B FRAGMENT (CYS2) Deposited 2001-08-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain E
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
Chain F
327–410(84 aa)
Fragment:CYS2, RESIDUES 328-411
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;0.17M NA ACETATE, 25.5% PEG8000, 0.1M CACODYLATE, PH6.5, pH 6.50
|
Resolution 2.30 Å R-free 0.262 |
| 1GK6 Human vimentin coil 2B fragment linked to GCN4 leucine zipper (Z2B) Deposited 2001-08-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
384–411(28 aa)
Fragment:Z2B FUSION CONSTRUCT CONTAINING THE GCN4 LEUCINE ZIPPER LINKED TO VIMENTIN RESIDUES 385 - 412
Chain B
384–411(28 aa)
Fragment:Z2B FUSION CONSTRUCT CONTAINING THE GCN4 LEUCINE ZIPPER LINKED TO VIMENTIN RESIDUES 385 - 412
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;HANGING DROPS WITH 12.5MG/ML PROTEIN AND 0.55M (NH4)2HPO4, PH ADJUSTED TO 9.0 WITH NAOH, AS PRECIPITANT
|
Resolution 1.90 Å R-free 0.227 |
| 3G1E X-ray crystal structure of coil 1A of human vimentin Deposited 2009-01-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
102–138(37 aa)
Fragment:coil 1A
Chain B
102–138(37 aa)
Fragment:coil 1A
|
Mutation:Y117L Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:Y117L Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;298 K;20 % PEG, 33 % isopropanol, 0.1 M trisodium citrate, pH 5.6, vapour diffusion, temperature 298K
|
Resolution 1.83 Å R-free 0.295 |
| 3KLT Crystal structure of a vimentin fragment Deposited 2009-11-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
263–334(72 aa)
Fragment:UNP residues 263-334
Chain B
263–334(72 aa)
Fragment:UNP residues 263-334
Chain C
263–334(72 aa)
Fragment:UNP residues 263-334
Chain D
263–334(72 aa)
Fragment:UNP residues 263-334
|
Not recorded | P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL × 1 SM SAMARIUM (III) ION × 3 P6G HEXAETHYLENE GLYCOL × 1 CA CALCIUM ION × 6 PG4 TETRAETHYLENE GLYCOL × 2 1PE PENTAETHYLENE GLYCOL × 1 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1M Bis-Tris pH 6.5, 27% PEG monoethylether 550, 27mM CaCl2, 7.5% (v/v) glycerol, 10mM DTT , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å R-free 0.331 |
| 3KLT Crystal structure of a vimentin fragment Deposited 2009-11-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
263–334(72 aa)
Fragment:UNP residues 263-334
Chain B
263–334(72 aa)
Fragment:UNP residues 263-334
|
Not recorded | P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL × 1 SM SAMARIUM (III) ION × 2 P6G HEXAETHYLENE GLYCOL × 1 CA CALCIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1M Bis-Tris pH 6.5, 27% PEG monoethylether 550, 27mM CaCl2, 7.5% (v/v) glycerol, 10mM DTT , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å R-free 0.331 |
| 3KLT Crystal structure of a vimentin fragment Deposited 2009-11-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
263–334(72 aa)
Fragment:UNP residues 263-334
Chain D
263–334(72 aa)
Fragment:UNP residues 263-334
|
Not recorded | SM SAMARIUM (III) ION × 1 CA CALCIUM ION × 4 PG4 TETRAETHYLENE GLYCOL × 2 1PE PENTAETHYLENE GLYCOL × 1 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1M Bis-Tris pH 6.5, 27% PEG monoethylether 550, 27mM CaCl2, 7.5% (v/v) glycerol, 10mM DTT , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å R-free 0.331 |
| 3S4R Crystal structure of vimentin coil1A/1B fragment with a stabilizing mutation Deposited 2011-05-20 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
99–189(91 aa)
Fragment:coil 1A/1B fragment (UNP residues 99-189)
Chain B
99–189(91 aa)
Fragment:coil 1A/1B fragment (UNP residues 99-189)
|
Mutation:Y117L Mutation:Y117L | GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;0.1M Na cacodylate, MPD 20%, Mg acetate 0.45M, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 277K
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;0.1M MES, MPD 35%, 0.35M Li2SO4, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.45 Å R-free 0.315 |
| 3SSU Crystal structure of vimentin coil1A/1B fragment Deposited 2011-07-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
99–189(91 aa)
Fragment:UNP residues 99-189
Chain B
99–189(91 aa)
Fragment:UNP residues 99-189
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;0.04M calcium acetate, 0.1M MES pH 6, isopropanol 6%, VAPOR DIFFUSION, HANGING DROP, temperature 277K
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.06M calcium acetate, 0.1M MES pH 5.5, isopropanol 6%, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å R-free 0.272 |
| 3SWK Crystal structure of vimentin coil1B fragment Deposited 2011-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
153–238(86 aa)
Fragment:coil 1B fragment (UNP residues 153-238)
Chain B
153–238(86 aa)
Fragment:coil 1B fragment (UNP residues 153-238)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;298 K;protein in 10 mM Tris pH 8, 38 mM NaCl + PEG 3350 25% w/v, 0.2M ammonium acetate, BIS-TRIS 0.1M pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.70 Å R-free 0.272 |
| 3TRT Crystal structure of stabilised vimentin coil2 fragment Deposited 2011-09-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
261–335(75 aa)
Fragment:first half of vimentin coil2, UNP residues 261-335
Chain B
261–335(75 aa)
Fragment:first half of vimentin coil2, UNP residues 261-335
|
Mutation:L265C, L269(MSE), C328(MSE) Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:L265C, L269(MSE), C328(MSE) Non-standard monomer:Yes (specific site not provided by mmCIF) | SO4 SULFATE ION × 4 GOL GLYCEROL × 3 NH4 AMMONIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;2M ammonium sulphate, 0.1M Tris pH8.5 + protein in 10 mM Tris pH 8, 38 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å R-free 0.298 |
| 3UF1 Crystal Structure of Vimentin (fragment 144-251) from Homo sapiens, Northeast Structural Genomics Consortium Target HR4796B Deposited 2011-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
144–251(108 aa)
Fragment:residues 144-255
Chain B
144–251(108 aa)
Fragment:residues 144-255
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5). Reservoir solution:NH4SO4 0.15M, TRISHCL 0.1M, PEG3350 18%, VAPOR DIFFUSION, HANGING DROP,
|
Resolution 2.81 Å R-free 0.284 |
| 3UF1 Crystal Structure of Vimentin (fragment 144-251) from Homo sapiens, Northeast Structural Genomics Consortium Target HR4796B Deposited 2011-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
144–251(108 aa)
Fragment:residues 144-255
Chain D
144–251(108 aa)
Fragment:residues 144-255
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5). Reservoir solution:NH4SO4 0.15M, TRISHCL 0.1M, PEG3350 18%, VAPOR DIFFUSION, HANGING DROP,
|
Resolution 2.81 Å R-free 0.284 |
| 4MCY Immune Receptor Deposited 2013-08-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
66–78(13 aa)
Fragment:UNP residues 66-78
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;26% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.30 Å R-free 0.225 |
| 4MCZ Immune Receptor Deposited 2013-08-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
59–71(13 aa)
Fragment:Residues 59-71
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;26% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.41 Å R-free 0.231 |
| 4MD0 Immune Receptor Deposited 2013-08-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
59–71(13 aa)
Fragment:Residues 59-71
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;24% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane pH 7.3
, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.19 Å R-free 0.208 |
| 4MD5 Immune Receptor Deposited 2013-08-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
66–78(13 aa)
Fragment:Residues 66-78
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 8 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;26% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 1.65 Å R-free 0.186 |
| 4MDI Immune Receptor Deposited 2013-08-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
66–78(13 aa)
Fragment:Residues 66-78
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;25% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.00 Å R-free 0.203 |
| 4MDJ Immune Receptor Deposited 2013-08-22 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
66–78(13 aa)
Fragment:Residues 66-78
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;294 K;25% PEG 3350, 0.2M Potassium Nitrate, 0.1M Bis-Tris-Propane pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 1.70 Å R-free 0.188 |
| 4YPC Trimeric crystal structure of vimentin coil1B fragment Deposited 2015-03-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: Trimeric |
Chain A
161–243(83 aa)
Fragment:coil 1B fragment, UNP residues 161-243
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;298 K;protein in 10 mM Tris pH 8, 38 mM NaCl mixed in ratio 1:1 with 1M Sodium citrate tribasic dihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5
|
Resolution 1.44 Å R-free 0.276 |
| 4YV3 Trimeric crystal structure of vimentin coil1B fragment Deposited 2015-03-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
161–238(78 aa)
Chain B
161–238(78 aa)
Chain C
161–238(78 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | SO4 SULFATE ION × 1 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;10mg/ml protein in 10mM Tris-HCl pH 8, 38 mM NaCl mixed in v/v ratio 1:1 with ammonium sulphate 2.2M, sodium thiocyanate 0.2 M
|
Resolution 2.00 Å R-free 0.296 |
| 5WHF Crystal structure of vimentin coil 1B packed in a high-order filamentous form Deposited 2017-07-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 16 PDB declaration: hexadecameric |
Chain A
153–238(86 aa)
Fragment:UNP residues 153-238
Chain B
153–238(86 aa)
Fragment:UNP residues 153-238
Chain C
153–238(86 aa)
Fragment:UNP residues 153-238
Chain D
153–238(86 aa)
Fragment:UNP residues 153-238
Chain E
153–238(86 aa)
Fragment:UNP residues 153-238
Chain F
153–238(86 aa)
Fragment:UNP residues 153-238
Chain G
153–238(86 aa)
Fragment:UNP residues 153-238
Chain H
153–238(86 aa)
Fragment:UNP residues 153-238
|
Not recorded | GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;294 K;0.1 M Bis-Tris pH 6.5, 0.2 M magnesium acetate tetrahydrate and 10% PEG 8000
|
Resolution 2.25 Å R-free 0.282 |
| 6YXK Crystal structure of ACPA 3F3 in complex with cit-vimentin 59-74 Deposited 2020-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
59–74(16 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20mM Tris pH 7.5, 20mM NaCl, 0.2M ammonium chloride pH 6.3, (20%) w/v PEG 3350)
|
Resolution 2.00 Å R-free 0.253 |
| 8RVE Vimentin intermediate filament Deposited 2024-02-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 78 PDB declaration: 78-meric |
Chain 0
1–466(466 aa)
Chain 1
1–466(466 aa)
Chain 2
1–466(466 aa)
Chain 3
1–466(466 aa)
Chain 4
1–466(466 aa)
Chain 5
1–466(466 aa)
Chain 6
1–466(466 aa)
Chain 7
1–466(466 aa)
Chain 8
1–466(466 aa)
Chain 9
1–466(466 aa)
Chain A
1–466(466 aa)
Chain AA
1–466(466 aa)
Chain AB
1–466(466 aa)
Chain AC
1–466(466 aa)
Chain AD
1–466(466 aa)
Chain AE
1–466(466 aa)
Chain AF
1–466(466 aa)
Chain AG
1–466(466 aa)
Chain AH
1–466(466 aa)
Chain AI
1–466(466 aa)
Chain AJ
1–466(466 aa)
Chain AK
1–466(466 aa)
Chain AL
1–466(466 aa)
Chain AM
1–466(466 aa)
Chain AN
1–466(466 aa)
Chain AO
1–466(466 aa)
Chain AP
1–466(466 aa)
Chain B
1–466(466 aa)
Chain C
1–466(466 aa)
Chain D
1–466(466 aa)
Chain E
1–466(466 aa)
Chain F
1–466(466 aa)
Chain G
1–466(466 aa)
Chain H
1–466(466 aa)
Chain I
1–466(466 aa)
Chain J
1–466(466 aa)
Chain K
1–466(466 aa)
Chain L
1–466(466 aa)
Chain M
1–466(466 aa)
Chain N
1–466(466 aa)
Chain O
1–466(466 aa)
Chain P
1–466(466 aa)
Chain Q
1–466(466 aa)
Chain R
1–466(466 aa)
Chain S
1–466(466 aa)
Chain T
1–466(466 aa)
Chain U
1–466(466 aa)
Chain V
1–466(466 aa)
Chain W
1–466(466 aa)
Chain X
1–466(466 aa)
Chain Y
1–466(466 aa)
Chain Z
1–466(466 aa)
Chain a
1–466(466 aa)
Chain b
1–466(466 aa)
Chain c
1–466(466 aa)
Chain d
1–466(466 aa)
Chain e
1–466(466 aa)
Chain f
1–466(466 aa)
Chain g
1–466(466 aa)
Chain h
1–466(466 aa)
Chain i
1–466(466 aa)
Chain j
1–466(466 aa)
Chain k
1–466(466 aa)
Chain l
1–466(466 aa)
Chain m
1–466(466 aa)
Chain n
1–466(466 aa)
Chain o
1–466(466 aa)
Chain p
1–466(466 aa)
Chain q
1–466(466 aa)
Chain r
1–466(466 aa)
Chain s
1–466(466 aa)
Chain t
1–466(466 aa)
Chain u
1–466(466 aa)
Chain v
1–466(466 aa)
Chain w
1–466(466 aa)
Chain x
1–466(466 aa)
Chain y
1–466(466 aa)
Chain z
1–466(466 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.20 Å |
| 8TRQ T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 Deposited 2023-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
59–71(13 aa)
Fragment:UNP residues 59-71 with modified residue citrulline (CIR) at position 64
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | GOL GLYCEROL × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% w/v PEG3350, 0.2 M di-sodium malonate, 0.1 M Bis-Tris propane, pH 6.5, tri-glycine additive
|
Resolution 2.75 Å R-free 0.264 |
| 8TRR T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 Deposited 2023-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
59–71(13 aa)
Fragment:UNP residues 59-71 with modified residue citrulline (CIR) at position 64
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | GOL GLYCEROL × 7 SO4 SULFATE ION × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% w/v PEG8000, 0.1 M Tris, pH 8.5, 0.2 M ammonium sulfate
|
Resolution 2.65 Å R-free 0.244 |
| 8TRR T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 Deposited 2023-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 5 PDB declaration: pentameric |
Chain H
59–71(13 aa)
Fragment:UNP residues 59-71 with modified residue citrulline (CIR) at position 64
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | GOL GLYCEROL × 3 SO4 SULFATE ION × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% w/v PEG8000, 0.1 M Tris, pH 8.5, 0.2 M ammonium sulfate
|
Resolution 2.65 Å R-free 0.244 |
22 other PDB entries and 28 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | VIME_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 3–39; UniProt 101–137 |